Kadian
Product Images NDC 16590-885

10 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Kadian (NDC 16590-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kadian 100mg Label (Kadian 100mg Label)

Kadian 100mg Label (Kadian 100mg Label)
KADIAN C-II label showing 100 mg strength in capsule dosage form with 112 capsules in the package. The product contains Morphine Sulfate 100 mg extended-release. Distributed by STAT RX USA LLC, the label includes the NDC 16590-740-73 and manufacturing details from Actavis Kadian LLC, Morristown, NJ.*
FDA Label Image

Kadian 200mg Label (Kadian 200mg Label)

Kadian 200mg Label (Kadian 200mg Label)
KADIAN C-II 200 mg extended release capsules, 90 count, packaged and distributed by STAT RX USA LLC in Gainesville, GA. Each capsule contains 200 mg Morphine Sulfate. The label includes NDC 16590-885-90, manufacturing details by Actavis Kadian LLC in Morristown, NJ, and storage instructions to keep out of reach of children and store between 59-86 degrees Fahrenheit.*
FDA Label Image

Kadian 20mg Label (Kadian 20mg Label)

Kadian 20mg Label (Kadian 20mg Label)
KADIAN 20mg capsule bottle label showing 56 capsules, distributed by STAT RX USA LLC. The label identifies the product as an extended-release Morphine Sulfate 20mg capsule, manufactured by Actavis Kadian LLC, Morristown, NJ. Includes NDC 16590-697-56 and warning to keep out of reach of children.*
FDA Label Image

Kadian 30mg Label (Kadian 30mg Label)

Kadian 30mg Label (Kadian 30mg Label)
KADIAN 30 mg extended-release capsules packaging label showing 56 capsules per bottle. The label includes the NDC 16590-660-56 and notes morphine sulfate as the active ingredient. Manufactured by Actavis Kadian LLC and distributed by Stat RX USA LLC. Label features dosage and safety warnings, including 'RX ONLY - KEEP OUT OF REACH OF CHILDREN.'*
FDA Label Image

Kadian 50mg Label (Kadian 50mg Label)

Kadian 50mg Label (Kadian 50mg Label)
Packaging label for KADIAN C-II 50mg extended-release capsules, 30 count, labeled by STAT RX USA LLC. The label includes the NDC 16590-606-30 and states each capsule contains 50mg morphine sulfate. Manufactured by Actavis Kadian LLC in Morristown, NJ. Warnings about prescription use and child safety are also visible.*
FDA Label Image

Kadian 60mg Label (Kadian 60mg Label)

Kadian 60mg Label (Kadian 60mg Label)
KADIAN C-II 60 mg extended release capsules, 30 count package label. Distributed by STAT RX USA LLC in Gainesville, GA. Contains Morphine Sulfate 60 mg per capsule. NDC 16590-598-30. Manufactured by Actavis Kadian LLC, Morristown, NJ. Includes cautionary statements and storage instructions.*
FDA Label Image

Kadian 80mg Label (Kadian 80mg Label)

Kadian 80mg Label (Kadian 80mg Label)
Label for KADIAN C-II capsules, each containing 80 mg morphine sulfate extended release. The bottle contains 60 capsules. Packaged and distributed by STAT RX USA LLC. Manufactured by Actavis Kadian LLC, Morristown, NJ. The label includes NDC 16590-778-60 and warnings for prescription use and storage instructions.*
FDA Label Image

Structure Image (Aa369910 Figure 01)

Structure Image (Aa369910 Figure 01)
Chemical structure diagram of the active ingredient in KADIAN, showing molecular bonds, rings, and functional groups, alongside notation indicating associated sulfate and water molecules (. H2SO4 . 5H2O).*
FDA Label Image

Graph 1 (Aa369910 Figure 02)

Graph 1 (Aa369910 Figure 02)
A line graph comparing plasma concentration (ng/mL) over time (hours) for KADIAN, morphine solution, and BID extended-release morphine tablet. The graph shows plasma concentration changes for each formulation from 0 to 12 hours, illustrating differences in drug release and absorption profiles.*
FDA Label Image

Graph 2 (Aa369910 Figure 03)

Graph 2 (Aa369910 Figure 03)
A line graph comparing plasma concentration (ng/mL) over time (hours) for KADIAN and BID extended-release morphine tablets. The graph shows plasma concentration curves for both products across a 24-hour period, illustrating variations in drug release and absorption profiles.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.